Open the map

GE HealthCareGEHC

Medtech & devices · NASDAQ · USA

$64.22
Down 0.7% todayClose

Down 21.2% this year and −2.3% since June 26, behind the life science sector at +10.7%. GE HealthCare supplies 1 mapped company.

This year
−21.2%
1 year
−13.2%
P/E
14.6
P/S
1.4
P/B
2.6

Price vs the life science sector

since Jun 26GEHCLife science sector, equal weight
GE HealthCare (GEHC) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. GEHC: −2.3% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%+15%Jun 26AugSepOct 8GEHC −2.3%Sector +10.7% GE HealthCare (GEHC) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. GEHC: −2.3% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%Jun 26AugSepOct 8GEHC−2.3%Sector+10.7%

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedCardinal Health (CAH)CAHCardinal Health+2.9%GEHCGE HealthCare Open the full chain →

About GE HealthCare

Imaging is the core: CT and MRI systems, plus ultrasound. Patient monitoring equipment and contrast agents round out a range sold worldwide.

Theme exposure

Medical imagingPatient monitoringDiagnostic equipment

Products

  • Imaging (CT/MRI)
  • Ultrasound
  • Patient monitoring & contrast agents

Competitors

  • Siemens Healthineers
  • Philips
  • Canon Medical

Risks

  • Hospital capex cycle
  • Supply chain

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Compare GEHC

Side by side with the largest companies in the same segment.

See where GE HealthCare sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →